Englewood Lab Inc (950140) — Cash Flow-to-Debt Ratio
Englewood Lab Inc (950140) has a Cash Flow-to-Debt Ratio of 0.09x as of September 2025, meaning its operating cash flow of ₩6.76 Billion could theoretically repay 0% of its total liabilities (₩75.21 Billion) in one year. See 950140 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Englewood Lab Inc Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Englewood Lab Inc across 10 annual periods. Also explore how fast is Englewood Lab Inc growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Englewood Lab Inc (2015–2024)
Year-by-year debt coverage analysis for Englewood Lab Inc. For market capitalisation and broader financial context, see Englewood Lab Inc (950140) total market value.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.25x | ₩9.47 Million | ₩37.98 Million | ▼ -29.1% |
| 2023 | 0.35x | ₩16.01 Million | ₩45.54 Million | ▼ -99.9% |
| 2022 | 286.13x | ₩9.56 Billion | ₩33.42 Million | ▲ +266.1% |
| 2021 | -172.30x | ₩-6.86 Billion | ₩39.84 Million | ▼ -204.3% |
| 2020 | 165.26x | ₩7.30 Billion | ₩44.16 Million | ▼ -36.1% |
| 2019 | 258.73x | ₩12.12 Billion | ₩46.83 Million | ▲ +218.7% |
| 2018 | -217.92x | ₩-9.37 Billion | ₩42.99 Million | ▲ +27.3% |
| 2017 | -299.60x | ₩-8.98 Billion | ₩29.98 Million | ▼ -82360.6% |
| 2016 | -0.36x | ₩-2.90 Million | ₩7.99 Million | ▼ -529.9% |
| 2015 | -0.06x | ₩-1.13 Billion | ₩19.56 Billion | — |